SpeedWeed

MARCH 13, 2021

Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. More Than 1,000 PD Patients Surveyed.

Patients 52

Patients Treatment Therapy Sleep 52

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business.

Marijuana 205

Marijuana Legalization Programs Oil 205

United Patients Group

FEBRUARY 7, 2023

Inflammation can lead to a wide range of diseases and conditions, including heart disease, arthritis and cancer. This article will cover some common uses for medical cannabis when treating inflammation or pain along with what other ingredients might be helpful in reducing symptoms related to these conditions!

Cannabinoids 115

Cannabinoids Chronic Pain Terpenes THC 115

NORML

MARCH 14, 2019

Blumenauer said, “For too long, our veterans have been denied access to highly effective medical marijuana treatment for conditions like chronic pain and PTSD. Medical marijuana has shown proven benefits for treating these conditions denying our veterans access to them is shameful. Send a message now to your lawmakers.

Access 207

Access Chronic Pain Treatment Conditions 207

NORML

NOVEMBER 8, 2019

Polling from the American Legion shows that nearly 1 in 4 veterans consume marijuana to alleviate symptoms of a medical or physical condition. Prohibiting VA doctors from recommending cannabis to qualifying patients, while continuing to rely on pharmaceuticals drugs like opioids as a treatment, is both a dangerous and illogical policy.

Access 200

Access Marijuana Treatment Legislation 200

Cannabis Law Report

JUNE 28, 2021

His blend of medical, governmental, and healthcare policy experience makes him well positioned to support Kanabo’s mission to establish and lead a regulated medicinal cannabis market in the UK and Europe. Avihu Tamir, CEO, Kanabo Group, said , “We are delighted to welcome Dr Dan Poulter, MP as a Non-Executive Director to our board.

Research and Development 105

Research and Development Chronic Pain Medicine Policy 105

Veriheal

JUNE 19, 2023

The prominent players, as explained by the psychedelic market report, include Pfizer, Verrian, GlaxoSmithKline, COMPASS Pathways PLC, MindMed, Janssen Pharmaceuticals PLC, HAVN Life Sciences, Seelos Therapeutics, Field Trip Health, amongst others. LSD can be used to deal with anxiety due to stress as well as depression.

Therapy 109

Therapy Treatment Patients Policy 109

United Patients Group

FEBRUARY 2, 2023

The cannabinoids found within cannabis have been shown to help boost our natural defenses against illness by improving our overall health status rather than just treating symptoms like most pharmaceuticals do (i.e., The post Using Cannabis For Health and Wellness appeared first on United Patients Group. antibiotics).

Blood Pressure 104

Blood Pressure Sleep Chronic Pain Digestion 104

Cannabis Law Report

JULY 21, 2022

COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Kabir Nath as Chief Executive Officer, effective August 1, 2022. London, UK July 19, 2022.

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

The Cannigma

JUNE 1, 2021

Marijuana is not legal in France, and the country is seen as having some of the strictest cannabis policies in western Europe. Under the plan, some 3,000 patients in France will be treated with medical cannabis and monitored closely. Such patients can only receive a 30 day supply and must renew the prescription every six months.

Law 113

Law Epilepsy Programs Patients 113

MMJ Recs

JUNE 26, 2020

The Sooner State has more dispensaries than any other state, as well as more MMJ patients per capita. When OK legalized MMJ in 2018, it began providing licenses to businesses and MMJ cards to patients almost right away. A lot was left up to the discretion of the MMJ industry, employers, medical professionals, and patients.

Marijuana 69

Marijuana Safety Pharmaceutical Patients 69

Veriheal

SEPTEMBER 22, 2021

We’re encouraged that SB711 has been advanced by the Judiciary Committee,” said DeVaughn Ward , who serves as senior legislative counsel for the Marijuana Policy Project. After enrollment, patients would need to be reevaluated by their healthcare practitioner/doctor for a minimum of one year.

Legalization 111

Legalization Patients Cultivation Legislation 111

NORML

JUNE 13, 2019

Millions of Americans are legally replacing pharmaceuticals with cannabis and the question of affordability has become critical. Certain conditions require more cannabinoids than others. Price caps that could favor seriously ill patients/consumers will be an entirely new concept to the cannabis industry, but it’s no innovation.

Marijuana 263

Marijuana Dispensary Patients Cannabinoids 263

Project CBD

MARCH 8, 2019

Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. As of February 2019, the Veterinary Medical Board in California still has no official policy on hemp products. Medical Cannabis in California.

Pets 215

Pets Legalization Hemp Extraction 215

NORML

JANUARY 11, 2019

Legislation is pending, Senate Bill 2134, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. The measure would permit patients to grow up to nine cannabis plants in a locked, enclosed facility, and to possess up to three ounces of home-grown medical cannabis. NH resident?

Legislation 187

Legislation Decriminalization Hemp Patients 187

NORML

FEBRUARY 29, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. The Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act (HR 3884 / S. HI resident? New Hampshire.

Legislation 144

Legislation Decriminalization Patients Edibles 144

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. It prompts considerations regarding patient access, treatment options, and healthcare provider involvement.

Legalization 52

Legalization Access Programs Education 52

MJ Business Attorneys

JUNE 29, 2018

The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome. The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Veriheal

DECEMBER 24, 2021

One of the original authors of the Compassionate Use of Medical Cannabis Pilot Program Act in 2013 (MCPP) — a law that led to the legalization of pharmaceutical-grade cannabis across the state of Illinois — says that growing demand and acceptance of the federally illegal plant has not reduced the risk of job loss.

Legislation 98

Legislation Recreational Patients Cannabis 98

NORML

FEBRUARY 1, 2019

At the state level, activists in Florida and Missouri gathered in their state capitals along side state and local NORML chapters to lobby state lawmakers in favor of sensible marijuana policy reform. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed.

Legislation 158

Legislation Decriminalization Access Patients 158

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. The State Government Affairs Lead will oversee MAPS PBC’s policy efforts at the state level.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

JUNE 3, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

Cannabis Law Report

MARCH 29, 2022

Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. Prior to his work at Moderna, Mullette developed broad pharmaceutical expertise with Sanofi in a variety of management roles in the U.S., Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. He holds a B.S.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

The Cannigma

AUGUST 29, 2021

The AARP, explaining its 2019 policy change, stated that its decision was based on “the growing body of research suggesting marijuana may be helpful in treating certain medical conditions and symptoms.”. If you live in a state that only has a medical cannabis card, then you’ll need to become a licensed patient.

Blood Pressure 87

Blood Pressure Marijuana Conditions Sleep 87

The Cannigma

MARCH 25, 2021

Executive Director of the Criminal Justice Policy Foundation told The Cannigma during a Zoom call this week. “A Sterling mentioned fears that officials may have about cannabis making its way out into the general population of the prison, though he added that’s a concern with any pharmaceutical provided by prison health services.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

NORML

FEBRUARY 8, 2019

Senator Ron Wyden introduced legislation in the Senate — The Marijuana Revenue and Regulation Act — to permit states to establish their own marijuana regulatory policies free from federal interference. Click here to email your lawmakers in opposition to restricting patients’ employment rights. CT resident?

Legislation 168

Legislation Decriminalization Patients Access 168

Cannabis Law Report

NOVEMBER 23, 2019

for the production R&D of pharmaceutical grade standardised cannabis. Here the company shares their evolution with Health Europa, exploring the production of pharmaceutical grade standardised cannabis. KANNABEIRA® is a project and a registered trademark under the company Green Donation, Ltd. KANNABEIRA and standardised cannabis.

Pharmaceutical 45

Pharmaceutical Research and Development Cultivation Environment 45

The Cannigma

OCTOBER 20, 2021

Furthermore, in 2017 the Norwegian parliament voted in favor of a measure to decriminalize drug use, shifting the focus of drug policies towards treatment. Since 2018, the Norwegian Medicines Agency allows doctors approved by the agency to prescribe medical cannabis for patients on a case-by-case basis.

Legalization 59

Legalization Decriminalization Patients Medicine 59

Veriheal

OCTOBER 29, 2020

Is the focus on the negative impact due to the fact that role players want cannabis to remain illicit as to avoid its potential role in replacing pharmaceutical medication? Scenario 2: Pharmaceuticals. However, the focus of funding remains on negative impacts. How could we move the focus towards understanding the benefits?

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

Cannabis Law Report

MARCH 1, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

OCTOBER 2, 2021

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. “ Off-label use ” (which is extremely common) is: the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration.

Therapy 89

Therapy Legalization Chronic Pain DEA 89

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. billion, servicing nearly 340,000 active patients. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 to reach 3.2

Programs 100

Programs Data Events Collective 100

SMPL

MAY 28, 2020

The expansion proposal, which the House of Representatives approved last week, would allow physicians to recommend medical cannabis to patients for any debilitating condition that they deem fit instead of from the limited list of maladies that’s used under current law. House Bill 819 is the new standard for medical marijuana programs.

Marijuana 40

Marijuana Legislation Conditions Banking 40

CannaMD

MARCH 8, 2021

If you’re a Florida medical marijuana patient, chances are you’ve heard of House Bill 1455 – a proposed bill making its rounds through the state legislature as we speak. But, behind the outrage, lies a larger conversation regarding free speech, fair pricing, and the sanctity of the physician-patient relationship.

THC 116

THC Research and Development Treatment Patients 116

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. POPLAR will publish original law and policy research. CR: Can you describe the existing landscape of psychedelics research?

Law 105

Law Research and Development Therapy DEA 105